Hutch News
Results per Page:
Flipping out to develop an intracellular protein-targeting CAR T cell therapy to treat AML
From the Meshinchi Lab, Clinical Research and Translational Science and Therapeutics Divisions.
Project Stella enables novel pediatric AML immunotherapies, potential cure
Fred Hutch's Dr. Soheil Meshinchi's lab identifies potential drug while also developing immunotherapy thanks to fundraising
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Models of pediatric acute megakaryoblastic leukemia lead to new potential therapies
From the Meshinchi Lab, Clinical Research Division
Examining genomic features of infant acute myeloid leukemia
From the Meshinchi Lab, Clinical Research Division
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
Send in the CARs: mesothelin-targeted CAR T cells against AML
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Taking aim: Mesothelin as a novel target for pediatric AML therapy
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Dr. Stanley Riddell awarded Burke O'Reilly Family Endowed Chair in Immunotherapy
Inspired by child's life-threatening illness, family's gift funds development of next-gen therapies
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more
The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
From Omaha to a Seattle lab, with 2 side trips to hell
Childhood AML survivor interns with the scientist who sequenced her genome
Pediatric acute myeloid leukemia targeted therapies come of age
From Dr. Hamid Bolouri, Human Biology and Dr. Soheil Meshinchi, Clinical Research Divisions
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more
Big data in cancer research
New study in childhood leukemia illustrates challenges and power of cutting-edge genomic technologies’ huge data sets
‘Remarkable’ distinctions in pediatric leukemia point toward improved treatment
Big new study in pediatric and young adult acute myeloid leukemia warns against ‘trickle-down therapeutics’
Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia
Hutch-based repository leads to lifesaving treatments for young cancer patient
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
The quest to better understand the deadliest childhood leukemia
Oncologists are beginning to leverage unique genomic characteristics of pediatric AML to improve treatment and prognosis